BioSpace News Archive

LegoChem Biosciences, Inc. (“LCB”) (KOSDAQ:141080), based in Daejeon, South Korea, announced today that it has entered a research collaboration and license agreement with Iksuda Therapeutics (“Iksuda”) for the development of antibody-drug conjugates in oncology.

Sino Biological, Inc. today announced a co-development agreement with Nanommune Inc., an Irvine, California based biotechnology company specializing in the development and application of multiplex array technology. Under the terms of the agreement, the two companies will jointly develop coronavirus antigen array products for serological studies of COVID-19 and other infectious diseases.

iSpecimen today announced it is deeply engaged in the battle against COVID-19, supporting researchers who are working on urgently needed vaccines, tests and treatments for the deadly viral disease.

Tampa General Hospital is one of the first hospitals in Florida participating in several national research studies seeking effective ways to treat COVID-19

Cygnal Therapeutics today announced the publication of a new article in Cell, titled “Roadmap for the Emerging Field of Cancer Neuroscience.” Jonathan Hurov, Ph.D., who serves as Cygnal’s vice president of discovery biology and platforms, and multiple members of Cygnal’s Scientific Advisory Board are co-authors on the paper, among other scientists.

Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) (the “Company” or “RTSL”), a fully-reporting company with the U.S. Securities and Exchange Commission, is an innovative biotech company specializing in aerosol delivery of legal cannabinoids to the systemic blood stream though the pulmonary route of administration.

Rafarma Pharmaceuticals, Inc. is pleased to announce acquisition of all outstanding US and Australian patents from Vladislav Laskavy, PhD.

The shareholders in Orexo AB, reg. no. 556500-0600, registered office Uppsala, are summoned to the extraordinary general meeting, to be held on Tuesday 19 May 2020, at 11.00 am in Orexo’s facilities at Rapsgatan 7E in Uppsala, Sweden.

MedTest Dx, Inc., an established solution provider for clinical diagnostic testing, is providing a critical tool in the fight against COVID-19 with its Pointe Scientific-branded assay for the highly sensitive quantification of G6PD in whole blood.

Twisted Ceptors, LLC announces PET/CT Imaging of Berkeley who have completed integration with the MIMIC Diagnostic Sharing Network.